Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers

Cancer Cell - United States
doi 10.1016/j.ccell.2017.03.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Harnessing the mTOR Pathway for Tuberculosis Treatment

Frontiers in Microbiology
Microbiology
2018English

Harnessing the Untapped Potential of Nucleotide‐binding Oligomerization Domain Ligands for Cancer Immunotherapy

Medicinal Research Reviews
Drug DiscoveryMolecular MedicinePharmacology
2018English

The Challenge of Developing New Therapies for Childhood Cancers

Oncologist
Cancer ResearchMedicineOncology
1997English

Nanoparticles for the Treatment of Lung Cancers

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2018English

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2017English

Dose Intensity of Chemotherapy for Childhood Cancers

Oncologist
Cancer ResearchMedicineOncology
1996English

MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

Gene Editing in Dermatology: Harnessing CRISPR for the Treatment of Cutaneous Disease

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2020English

Harnessing Pharmacogenomics to Guide the Treatment of LRBA Deficiency

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy